Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This study is a phase 1b clinical trial to investigate the safety and preliminary effects of
a single dose of a test drug or placebo to the subjects who has diagnosed as COVID-19
infection.